Immunome, Inc. (IMNM)
NASDAQ·Healthcare·Biotechnology
$23.68
+0.81%
Mkt Cap $2.10B
Next Earnings
In 12 daysMon, May 11, 2026
EPS Estimate
-$0.60
9 analysts
Revenue Estimate
$222.22K
Last quarter: missed by -27.08% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$2.10B
P/E
—
Fwd P/E
—
P/S
301.90
Rev TTM
—
EPS TTM
-$2.43